Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Shares Issued: 2023-2024

Historic Shares Issued for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $406.4 million.

  • CG Oncology's Shares Issued was N/A to $48.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $272.1 million, marking a year-over-year change of. This contributed to the annual value of $406.4 million for FY2024, which is 19420.17% up from last year.
  • Per CG Oncology's latest filing, its Shares Issued stood at $406.4 million for FY2024, which was up 19,420.17% from $2.1 million recorded in FY2023.
  • Over the past 5 years, CG Oncology's Shares Issued peaked at $406.4 million during FY2024, and registered a low of $2.1 million during FY2023.
  • Over the past 2 years, CG Oncology's median Shares Issued value was $204.2 million (recorded in 2023), while the average stood at $204.2 million.
  • Data for CG Oncology's Shares Issued shows a peak YoY soared of 19,420.17% (in 2024) over the last 5 years.
  • CG Oncology's Shares Issued (Yearly) stood at $2.1 million in 2023, then soared by 19,420.17% to $406.4 million in 2024.